small molecule

LEVOMILNACIPRAN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand name	LEVOMILNACIPRAN HYDROCHLORIDE
Active ingredient	LEVOMILNACIPRAN HYDROCHLORIDE
Strength	EQ 20MG BASE
Dosage form	CAPSULE, EXTENDED RELEASE
Route	ORAL
Modality	Small molecule
FDA approval	February 2019
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.